You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Carbonic Anhydrase IX antibody (ab15086)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab15086? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab15086 has been referenced in 14 publications.

  1. Smeland E et al. Prognostic impacts of hypoxic markers in soft tissue sarcoma. Sarcoma 2012:541650 (2012). IHC-P; Human. PubMed: 22454562
  2. Brockton N et al. High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors. Int J Radiat Oncol Biol Phys 80:249-57 (2011). IHC-P; Human. PubMed: 21300470
  3. Ameri K et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br J Cancer 102:561-9 (2010). WB; Human. PubMed: 20051957
  4. Lancashire LJ et al. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast Cancer Res Treat 120:83-93 (2010). Human. PubMed: 19347577
  5. Ilie M et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer : (2010). IHC-P; Human. PubMed: 20461082
  6. Tailor TD et al. Effect of pazopanib on tumor microenvironment and liposome delivery. Mol Cancer Ther 9:1798-808 (2010). IHC-Fr; Mouse. PubMed: 20515941
  7. Skowronski K et al. Ischemia dysregulates DNA methyltransferases and p16(INK4a) methylation in human colorectal cancer cells. Epigenetics 5: (2010). IHC-P; Human. PubMed: 20543577
  8. Blank A et al. SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling. Endocr Relat Cancer 17:919-28 (2010). IHC-P; Human. PubMed: 20702724
  9. Tennant DA et al. Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene 28:4009-21 (2009). IHC-P; Human. PubMed: 19718054
  10. Qayum N et al. Tumor vascular changes mediated by inhibition of oncogenic signaling. Cancer Res 69:6347-54 (2009). IHC. PubMed: 19622766
  11. Gimelli S et al. The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma. Mol Cancer 8:52 (2009). IHC-P; Human. PubMed: 19642973
  12. Korkeila E et al. Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer 100:874-80 (2009). WB, IHC-P; Human. PubMed: 19240720
  13. Schmitt AM et al. VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors. Endocr Relat Cancer 16:1219-27 (2009). PubMed: 19690016
  14. Jackson IL et al. Superoxide dismutase mimetic reduces hypoxia-induced O2*-, TGF-beta, and VEGF production by macrophages. Free Radic Res 41:8-14 (2007). PubMed: 17164174

Publishing research using ab15086? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"